Levetiracetam
NDC 68001-113, Levetiracetam, tablet, extended release, from BluePoint Laboratories.
- Product NDC
- 68001-113
- Status
- Listed
- Labeler
- BluePoint Laboratories
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA091399
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68001-113 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LEVETIRACETAM500 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68001-113-06 | 68001011306 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68001-113-06) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/402b488c-1733-4bf7-a7a8-b60805b022c9NADAC price for package 68001011306
GET /v1/drugs/nadac/68001011306
Use it
Look up 68001-113 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68001-113 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68001-113. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.